GeneDx Holdings Corp (NASDAQ: WGS) is 31.41% higher on its value in year-to-date trading and has touched a low of $7.59 and a high of $115.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The WGS stock was last observed hovering at around $99.13 in the last trading session, with the day’s gains setting it 1.87%.
Currently trading at $101.00, the stock is 21.88% and 25.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing 1.89% at the moment leaves the stock 91.52% off its SMA200. WGS registered 1142.31% gain for a year compared to 6-month gain of 183.79%.
The stock witnessed a 27.46% loss in the last 1 month and extending the period to 3 months gives it a 28.32%, and is -0.57% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.49% over the week and 10.98% over the month.
GeneDx Holdings Corp (WGS) has around 1000 employees, a market worth around $2.83B and $305.45M in sales. Fwd P/E is 53.58. Profit margin for the company is -17.12%. Distance from 52-week low is 1230.70% and -12.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.60%).
with sales reaching $79.9M over the same period.The EPS is expected to grow by 248.68% this year, but quarterly earnings will post 17.40% year-over-year. Quarterly sales are estimated to grow 27.99% in year-over-year returns.
The shares outstanding are 28.02M, and float is at 24.45M with Short Float at 11.27%.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 3.53 million shares valued at $92.18 million. The investor’s holdings represent 13.2482 of the WGS Shares outstanding. As of 2024-06-30, the second largest holder is CORVEX MANAGEMENT LP with 2.47 million shares valued at $64.66 million to account for 9.2937 of the shares outstanding. The other top investors are ORACLE INVESTMENT MANAGEMENT INC which holds 1.11 million shares representing 4.1542 and valued at over $28.9 million, while GOLDMAN SACHS GROUP INC holds 3.9517 of the shares totaling 1.05 million with a market value of $27.5 million.
GeneDx Holdings Corp (WGS) Insider Activity
GeneDx Holdings Corp disclosed in a document filed with the SEC on Jan 29 ’25 that Feeley Kevin (CHIEF FINANCIAL OFFICER) sold a total of 275 shares of the company’s common stock. The trade occurred on Jan 29 ’25 and was made at $78.48 per share for $21582.0. Following the transaction, the insider now directly holds 2950.0 shares of the WGS stock.
Still, SEC filings show that on Jan 29 ’25, Stueland Katherine (Chief Executive Officer) disposed off 1,657 shares at an average price of $78.48 for $0.13 million. The insider now directly holds 3,937 shares of GeneDx Holdings Corp (WGS).
